
Sign up to save your podcasts
Or


In this episode of This Is Purdue, we’re featuring a Boilermaker whose innovations are changing and saving lives across the world.
Philip Low, Purdue University’s Presidential Scholar for Drug Discovery and the Ralph C. Corley Distinguished Professor of Chemistry, developed a recently FDA-approved drug called Cytalux, a fluorescent marker that allows cancer surgeons to quickly identify malignant cells and remove them during surgery.
Listen in as Professor Low discusses how the drug works, why the team started using this drug on ovarian cancer patients first, and what attracted him to innovation at Purdue University. (Hint: He’s been a Boilermaker since birth!)
Learn more about your ad choices. Visit megaphone.fm/adchoices
By Purdue University4.6
119119 ratings
In this episode of This Is Purdue, we’re featuring a Boilermaker whose innovations are changing and saving lives across the world.
Philip Low, Purdue University’s Presidential Scholar for Drug Discovery and the Ralph C. Corley Distinguished Professor of Chemistry, developed a recently FDA-approved drug called Cytalux, a fluorescent marker that allows cancer surgeons to quickly identify malignant cells and remove them during surgery.
Listen in as Professor Low discusses how the drug works, why the team started using this drug on ovarian cancer patients first, and what attracted him to innovation at Purdue University. (Hint: He’s been a Boilermaker since birth!)
Learn more about your ad choices. Visit megaphone.fm/adchoices

108 Listeners

80 Listeners

7,688 Listeners

856 Listeners

4,310 Listeners

34 Listeners

6,563 Listeners

9 Listeners

21 Listeners

13 Listeners

1,849 Listeners

18,392 Listeners

10,254 Listeners

42 Listeners

38 Listeners